05/11/2021 - General information
A study led by the Colon and Rectal Surgery Unit, part of the Surgery Service at Hospital del Mar, has received two research grants, one from the Catalan Society of Surgery during the inaugural ceremony of the academic year on 15 October; and another from the Spanish Association of Coloproctology, during the organisation's conference, held from 20 to 22 October.
The funding goes towards a multicentre project entitled 'Determining proangiogenic proteins in serum as a prognostic factor for recurrence after curative colon cancer surgery', led by Dr. Marta Pascual, head of the Colon and Rectal Surgery Unit, and Dr. Clara Téllez, a resident in the same department, in collaboration with Dr. Xavier Mayol, a researcher in the Cancer Research Programme at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar).
The study aims to demonstrate which factors are prognostic of neoplastic recurrence after curative colon cancer surgery. Using patient samples, the proteins related to angiogenesis, the essential process for tumour growth, will be determined.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
